NDC 0069-2025

Comirnaty

Covid-19 Vaccine, Mrna

Comirnaty is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Tozinameran.

• Product ID: 0069-2025_082353dd-2add-43a0-ad60-aba8a6818372
• NDC: 0069-2025
• Product Type: Vaccine
• Proprietary Name: Comirnaty
• Generic Name: Covid-19 Vaccine, Mrna
• Dosage Form: Injection, Suspension
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2022-05-18
• Marketing Category: BLA /
• Application Number: BLA125742
• Labeler Name: Pfizer Laboratories Div Pfizer Inc
• Substance Name: TOZINAMERAN
• Active Ingredient Strength: 0 mg/2.25mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0069-2025-10

10 VIAL, GLASS in 1 CARTON (0069-2025-10) > 2.25 mL in 1 VIAL, GLASS (0069-2025-01)

• Marketing Start Date: 2022-05-18
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Comirnaty" or generic name "Covid-19 Vaccine, Mrna"

NDC	Brand Name	Generic Name
0069-2025	Comirnaty	COVID-19 Vaccine, mRNA
61434-043	SPIKEVAX	COVID-19 Vaccine, mRNA
80777-100	Spikevax	COVID-19 Vaccine, mRNA